ImmunoPrecise Antibodies Ltd. is a full-service, antibody discovery CRO focused on the next generation of antibody discovery. We aim to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with highest probability of succeeding to clinical trials.
IPA is a single source provider of services for the complete antibody discovery value chain. We offer the most comprehensive collection of antibody discovery platforms in the industry, combined with state of the art lead candidate optimization and characterization. This allows us to assist clients from the moment they identify a therapeutic target to the preparation of applying for investigation review of the clinical product.